Add to ORKGIs 5 days of antibiotic therapy really sufficient for adults hospitalized with community-acquired pneumonia? PRACTICE CHANGER: Prescribe 5 days of antibiotic treatment for inpatients with community-acquired pneumonia because it produces the same clinical success rates as longer treatment regimens, but is associated with fewer negative patient outcomes
BACKGROUND: Lower respiratory tract infection (LRTI) is the third leading cause of death worldwide a...
The optimal guidelines for the treatment of community-acquired pneumonia are not well established, a...
BACKGROUND The choice of empirical antibiotic treatment for patients with clinically suspected commu...
In 2019, guidelines for the management of immunocompetent adults with community-acquired pneumonia (...
Background.Previous studies suggest that duration of antibiotic therapy for community-acquired pneum...
International experts suggest tailoring antibiotic duration in community-acquired pneumonia (CAP) ac...
Reduction of the inappropriate use of antibiotics in clinical practice is one of the main goals of t...
Introduction: Hospital-based antimicrobial stewardship efforts have traditionally focused on inpatie...
AbstractThere are no studies to guide the optimal duration of therapy in severe community-acquired p...
Recent guidelines suggest that duration of antibiotic therapy for hospitalized patients with communi...
Background: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide...
Till today, the duration of antibiotic therapy for community-acquired pneumonia (EP) remains a subje...
Purpose: To evaluate duration of antibiotic therapy and prescribing patterns for non-ICU CAP at St C...
This adjunct medication can speed CAP recovery: Adding prednisone to the antibiotic regimen can help...
The increased emphasis on pneumonia-related performance measures and patient outcomes has led hospit...
BACKGROUND: Lower respiratory tract infection (LRTI) is the third leading cause of death worldwide a...
The optimal guidelines for the treatment of community-acquired pneumonia are not well established, a...
BACKGROUND The choice of empirical antibiotic treatment for patients with clinically suspected commu...
In 2019, guidelines for the management of immunocompetent adults with community-acquired pneumonia (...
Background.Previous studies suggest that duration of antibiotic therapy for community-acquired pneum...
International experts suggest tailoring antibiotic duration in community-acquired pneumonia (CAP) ac...
Reduction of the inappropriate use of antibiotics in clinical practice is one of the main goals of t...
Introduction: Hospital-based antimicrobial stewardship efforts have traditionally focused on inpatie...
AbstractThere are no studies to guide the optimal duration of therapy in severe community-acquired p...
Recent guidelines suggest that duration of antibiotic therapy for hospitalized patients with communi...
Background: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide...
Till today, the duration of antibiotic therapy for community-acquired pneumonia (EP) remains a subje...
Purpose: To evaluate duration of antibiotic therapy and prescribing patterns for non-ICU CAP at St C...
This adjunct medication can speed CAP recovery: Adding prednisone to the antibiotic regimen can help...
The increased emphasis on pneumonia-related performance measures and patient outcomes has led hospit...
BACKGROUND: Lower respiratory tract infection (LRTI) is the third leading cause of death worldwide a...
The optimal guidelines for the treatment of community-acquired pneumonia are not well established, a...
BACKGROUND The choice of empirical antibiotic treatment for patients with clinically suspected commu...